Skip to content
Accessibility help
Search NICE…
Menu
Sign in
Guidance
Standards and indicators
Clinical Knowledge Summaries (CKS)
British National Formulary (BNF)
BNF for Children (BNFC)
Life sciences
More from NICE
Home
NICE guidance
Published
Published: Guidance, quality standards and advice
Skip to filters
Skip to results
Published
In consultation
In development
Deferred
Awaiting development
Topic prioritisation
Filter (1 applied)
Skip to results
Keyword or reference number
Keyword or reference number
Apply filter
Last updated date
Last updated date
From date
To date
Apply date filters
Area of interest
Area of interest
Antimicrobial prescribing (21)
COVID-19 (7)
Type
(
1 selected
)
Type
Guidance (2027)
NICE advice (319)
Quality standard (199)
Guidance programme
Guidance programme
Antimicrobial prescribing guidelines (21)
Antimicrobial resistance guidance (2)
Cancer service guidelines (5)
Clinical guidelines (229)
COVID-19 rapid guidelines (8)
HealthTech guidance (769)
Highly specialised technologies guidance (30)
Medicines practice guidelines (5)
NICE guidelines (336)
Public health guidelines (56)
Safe staffing guidelines (2)
Social care guidelines (69)
Technology appraisal guidance (890)
Apply filters
Showing 1151 to 1200 of 2027
Sort by
Date
Title
Apply sorting
Type: Guidance
`Remove $Type: Guidance filter`
Published guidance, NICE advice and quality standards
Title
Reference number
Published
Last updated
Glecaprevir–pibrentasvir for treating chronic hepatitis C
TA499
24 January 2018
24 January 2018
Age-related macular degeneration
NG82
23 January 2018
23 January 2018
Golimumab for treating active non-radiographic axial spondyloarthritis
TA497
10 January 2018
10 January 2018
Autism spectrum disorder in under 19s: recognition, referral and diagnosis
CG128
28 September 2011
20 December 2017
Palbociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
TA495
20 December 2017
20 December 2017
Ribociclib with an aromatase inhibitor for previously untreated, hormone receptor-positive, HER2-negative, locally advanced or metastatic breast cancer
TA496
20 December 2017
20 December 2017
Artificial heart implantation as a bridge to transplantation for end-stage refractory biventricular heart failure
HTG459
20 December 2017
20 December 2017
Subcutaneous implantable cardioverter defibrillator insertion for preventing sudden cardiac death
HTG460
20 December 2017
20 December 2017
Endobronchial valve insertion to reduce lung volume in emphysema
HTG457
20 December 2017
20 December 2017
Transcutaneous microwave ablation for severe primary axillary hyperhidrosis
HTG458
20 December 2017
20 December 2017
Atrial fibrillation and heart valve disease: self-monitoring coagulation status using point-of-care coagulometers (the CoaguChek XS system)
HTG353
24 September 2014
19 December 2017
Transvaginal mesh repair of anterior or posterior vaginal wall prolapse
HTG456
15 December 2017
15 December 2017
Naltrexone–bupropion for managing overweight and obesity
TA494
12 December 2017
12 December 2017
Vismodegib for treating basal cell carcinoma
TA489
22 November 2017
22 November 2017
Processed nerve allografts to repair peripheral nerve discontinuities
HTG454
22 November 2017
22 November 2017
Hypoglossal nerve stimulation for moderate to severe obstructive sleep apnoea
HTG455
22 November 2017
22 November 2017
Trastuzumab emtansine for treating HER2-positive advanced breast cancer after trastuzumab and a taxane
TA458
19 July 2017
20 November 2017
Tests in secondary care to identify people at high risk of ovarian cancer
HTG453
15 November 2017
15 November 2017
Regorafenib for previously treated unresectable or metastatic gastrointestinal stromal tumours
TA488
15 November 2017
15 November 2017
Total distal radioulnar joint replacement for symptomatic joint instability or arthritis
HTG451
8 November 2017
8 November 2017
Extracranial to intracranial bypass for intracranial atherosclerosis
HTG452
8 November 2017
8 November 2017
Aflibercept for treating choroidal neovascularisation
TA486
1 November 2017
1 November 2017
Sarilumab for moderate to severe rheumatoid arthritis
TA485
1 November 2017
1 November 2017
Sinusitis (acute): antimicrobial prescribing
NG79
27 October 2017
27 October 2017
Cataracts in adults: management
NG77
26 October 2017
26 October 2017
Cystic fibrosis: diagnosis and management
NG78
25 October 2017
25 October 2017
Hepatitis B (chronic): diagnosis and management
CG165
26 June 2013
20 October 2017
Tofacitinib for moderate to severe rheumatoid arthritis
TA480
11 October 2017
11 October 2017
Immunosuppressive therapy for kidney transplant in adults
TA481
11 October 2017
11 October 2017
Immunosuppressive therapy for kidney transplant in children and young people
TA482
11 October 2017
11 October 2017
Child abuse and neglect
NG76
9 October 2017
9 October 2017
Autologous chondrocyte implantation for treating symptomatic articular cartilage defects of the knee
TA477
4 October 2017
4 October 2017
Brentuximab vedotin for treating relapsed or refractory systemic anaplastic large cell lymphoma
TA478
4 October 2017
4 October 2017
Reslizumab for treating severe eosinophilic asthma
TA479
4 October 2017
4 October 2017
Faltering growth: recognition and management of faltering growth in children
NG75
27 September 2017
27 September 2017
Intramuscular diaphragm stimulation for ventilator-dependent chronic respiratory failure caused by motor neurone disease
HTG450
27 September 2017
27 September 2017
Cetuximab and panitumumab for previously untreated metastatic colorectal cancer
TA439
29 March 2017
25 September 2017
Intermediate care including reablement
NG74
22 September 2017
22 September 2017
Type 2 diabetes: prevention in people at high risk
PH38
12 July 2012
15 September 2017
High-intensity focused ultrasound for symptomatic breast fibroadenoma
HTG449
13 September 2017
13 September 2017
Ab externo canaloplasty for primary open-angle glaucoma
HTG448
13 September 2017
13 September 2017
Pembrolizumab for treating PD-L1-positive non-small-cell lung cancer after chemotherapy
TA428
11 January 2017
12 September 2017
Pembrolizumab for treating advanced melanoma after disease progression with ipilimumab
TA357
7 October 2015
12 September 2017
Pembrolizumab for advanced melanoma not previously treated with ipilimumab
TA366
25 November 2015
12 September 2017
Fertility problems: assessment and treatment
CG156
20 February 2013
6 September 2017
Sorafenib for treating advanced hepatocellular carcinoma
TA474
6 September 2017
6 September 2017
Dimethyl fumarate for treating moderate to severe plaque psoriasis
TA475
6 September 2017
6 September 2017
Paclitaxel as albumin-bound nanoparticles with gemcitabine for untreated metastatic pancreatic cancer
TA476
6 September 2017
6 September 2017
Psoriasis: assessment and management
CG153
24 October 2012
1 September 2017
Cetuximab for treating recurrent or metastatic squamous cell cancer of the head and neck
TA473
31 August 2017
31 August 2017
Previous page
1
…
22
23
Current page
24
25
26
…
41
Page
24
of
41
Next page
Results per page
10
25
50
All
Back to top